Get the Stockscreener App
1.98
3.66%
0.07
Lixte Biotechnology Holdings Inc Stock (LIXT) Forecast
The Lixte Biotechnology Holdings Inc (LIXT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.1539, representing a -41.72% decrease from the current price of $1.98. The highest analyst price target is $1.3534, and the lowest is $0.9544.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LIXT Price Target
Average 2.0952
(+5.82% Upside)
Is Lixte Biotechnology Holdings Inc (LIXT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.26 | Neutral |
| STOCH(9,6) | 40.30 | Neutral |
| STOCHRSI(14) | 17.19 | Buy |
| MACD(12,26) | 0.0479 | Sell |
| ADX(14) | 19.37 | Neutral |
| William %R | -78.82 | Neutral |
| CCI(14) | -10.12 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.9935
Sell
|
1.9988
Sell
|
| MA20 |
2.0108
Sell
|
1.9646
Buy
|
| MA50 |
1.8629
Buy
|
1.9166
Buy
|
| MA100 |
1.905
Buy
|
1.9769
Buy
|
| MA200 |
2.2766
Sell
|
2.1058
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, LIXT could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on LIXT, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 51.26 indicates that LIXT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.3 indicates that LIXT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 17.19 indicates that LIXT is oversold. This suggests that LIXT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.37 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -10.12 indicates that LIXT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LIXT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lixte Biotechnology Holdings Inc financial reports and earnings history, Lixte Biotechnology Holdings Inc (LIXT) stock could reach $0.9228 by 2030, $2.6056 by 2040 and $3.4619 by 2050. See the projected annual prices until 2050 of the Lixte Biotechnology Holdings Inc stock below:
- Lixte Biotechnology Holdings Inc (LIXT) is expected to reach an average price of $1.4264 in 2035, with a high prediction of $2.4464 and a low estimate of $0.2002. This indicates an $-27.96% rise from the last recorded price of $1.98.
- Lixte Biotechnology Holdings Inc (LIXT) stock is projected to chart a bullish course in 2040, with an average price target of $2.6356, representing an $33.11% surge from its current level. The forecast ranges from a conservative $2.6254 to a sky-high $2.6056.
- Our analysts predict Lixte Biotechnology Holdings Inc (LIXT) to jump -49.40% by 2045, soaring from $0.4358 to an average price of $1.0018, potentially reaching $3.46. While $0.4358 is the low estimate, the potential upside is significant.
- Lixte Biotechnology Holdings Inc (LIXT) stock is expected to climb by 2050, reaching an average of $3.2907, a $66.20% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.4619 and $3.4907, respectively, highlighting the market's uncertainty.
Lixte Biotechnology Holdings Inc Stock (LIXT) Year by Year Forecast
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2025
Lixte Biotechnology Holdings Inc Stock (LIXT) is expected to reach an average price of $2.0952 in 2025, with a high prediction of $4.1848 and a low estimate of $0.00561. This indicates an +5.82% rise from the last recorded price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.0973 | $0.9544 | $1.3534 | -44.58% |
| February, 2025 | $0.8699 | $0.7713 | $1.3383 | -56.07% |
| March, 2025 | $0.5352 | $0.3254 | $1.0342 | -72.97% |
| April, 2025 | $1.0901 | $0.3248 | $2.3181 | -44.94% |
| May, 2025 | $1.084 | $0.8512 | $1.2864 | -45.25% |
| June, 2025 | $0.578 | $0.436 | $1.115 | -70.81% |
| July, 2025 | $0.4329 | $0.3299 | $0.9195 | -78.14% |
| August, 2025 | $0.4168 | $0.3148 | $4.1848 | -78.95% |
| September, 2025 | $0.00154 | $0.0117 | $0.9678 | -99.92% |
| October, 2025 | $0.0479 | $0.0172 | $0.1437 | -97.58% |
| November, 2025 | $0.0696 | $0.00968 | $0.0946 | -96.49% |
| December, 2025 | $0.0165 | $0.00561 | $0.3835 | -99.17% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2026
The predicted value for Lixte Biotechnology Holdings Inc (LIXT) in 2026 is set at an average of $3.2429. Estimates vary from a peak of $6.4836 to a trough of $0.0021, indicating an +63.78% surge from the present price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0216 | $0.00548 | $0.1424 | -98.91% |
| February, 2026 | $0.1723 | $0.0759 | $0.1286 | -91.30% |
| March, 2026 | $0.2335 | $0.2267 | $0.1827 | -88.21% |
| April, 2026 | $0.0362 | $0.1488 | $0.1918 | -98.17% |
| May, 2026 | $0.2249 | $0.0222 | $0.1049 | -88.64% |
| June, 2026 | $0.0109 | $0.1604 | $0.1989 | -99.45% |
| July, 2026 | $0.414 | $0.012 | $1.983 | -79.09% |
| August, 2026 | $0.0029 | $0.0021 | $0.3849 | -99.85% |
| September, 2026 | $0.077 | $0.0408 | $0.2518 | -96.11% |
| October, 2026 | $0.0633 | $0.0842 | $0.0942 | -96.80% |
| November, 2026 | $0.0293 | $0.1036 | $0.0367 | -98.52% |
| December, 2026 | $4.3956 | $3.9226 | $6.4836 | +122.00% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lixte Biotechnology Holdings Inc (LIXT) is $4.8529, with a high forecast of $8.8075 and a low forecast of $0.8984. This indicates an +145.10% increase from the last price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.8295 | $2.5385 | $8.8075 | +42.90% |
| February, 2027 | $1.6534 | $1.5615 | $3.1201 | -16.49% |
| March, 2027 | $1.1784 | $0.8984 | $2.0554 | -40.49% |
| April, 2027 | $1.6923 | $1.1342 | $2.2703 | -14.53% |
| May, 2027 | $2.0762 | $1.2533 | $2.8062 | +4.86% |
| June, 2027 | $1.4355 | $1.3809 | $3.7492 | -27.50% |
| July, 2027 | $1.5851 | $1.2321 | $1.7794 | -19.95% |
| August, 2027 | $1.439 | $1.027 | $1.769 | -27.32% |
| September, 2027 | $1.9439 | $1.2439 | $2.1819 | -1.82% |
| October, 2027 | $1.5483 | $1.5045 | $2.0649 | -21.80% |
| November, 2027 | $2.8168 | $1.6038 | $3.7488 | +42.26% |
| December, 2027 | $2.712 | $1.69 | $3.1319 | +36.97% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2028
In 2028, Lixte Biotechnology Holdings Inc (LIXT) is projected to reach an average price of $1.5007, with a high projection of $2.9839 and a low estimate of $0.0175. This indicates an -24.21% fall from the last price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6598 | $1.4529 | $2.9839 | -16.17% |
| February, 2028 | $1.1177 | $0.7157 | $1.9718 | -43.55% |
| March, 2028 | $1.2875 | $0.8646 | $2.0636 | -34.97% |
| April, 2028 | $1.4054 | $1.1244 | $1.5295 | -29.02% |
| May, 2028 | $1.1352 | $1.0052 | $1.9509 | -42.67% |
| June, 2028 | $0.5931 | $0.48 | $2.5072 | -70.05% |
| July, 2028 | $0.5509 | $0.5009 | $1.287 | -72.18% |
| August, 2028 | $0.2807 | $0.1588 | $0.6029 | -85.82% |
| September, 2028 | $0.2486 | $0.2127 | $0.5466 | -87.44% |
| October, 2028 | $0.3535 | $0.0175 | $0.3006 | -82.14% |
| November, 2028 | $0.5763 | $0.3607 | $1.5363 | -70.89% |
| December, 2028 | $0.3841 | $0.0723 | $1.1682 | -80.60% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2029
The 2029 price forecast for Lixte Biotechnology Holdings Inc Stock (LIXT) is $1.7698 on average, with a high prediction of $3.4197 and a low estimate of $0.12. This represents an -10.61% decrease from the previous price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.126 | $0.12 | $0.4961 | -93.63% |
| February, 2029 | $0.2282 | $0.227 | $0.2201 | -88.48% |
| March, 2029 | $0.0397 | $0.3342 | $3.4197 | -98.00% |
| April, 2029 | $0.5716 | $0.3844 | $0.2464 | -71.13% |
| May, 2029 | $0.7525 | $0.7486 | $0.7366 | -61.99% |
| June, 2029 | $0.7692 | $0.7848 | $0.7349 | -61.15% |
| July, 2029 | $0.7449 | $0.7189 | $0.7028 | -62.38% |
| August, 2029 | $0.7071 | $0.739 | $0.6891 | -64.29% |
| September, 2029 | $0.9792 | $0.7751 | $0.7992 | -50.54% |
| October, 2029 | $0.9541 | $0.9353 | $0.914 | -51.81% |
| November, 2029 | $0.8815 | $0.9615 | $0.9235 | -55.48% |
| December, 2029 | $0.8312 | $0.7056 | $0.8546 | -58.02% |
Lixte Biotechnology Holdings Inc Stock (LIXT) Price Forecast for 2030
Lixte Biotechnology Holdings Inc Stock (LIXT) is expected to reach an average price of $4.1659 in 2030, with a high forecast of $8.1151 and a low forecast of $0.2167. This signifies an +110.40% surge from the last price of $1.98.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.8739 | $0.9239 | $0.9228 | -55.87% |
| February, 2030 | $0.646 | $0.7025 | $0.6919 | -67.37% |
| March, 2030 | $0.5206 | $0.4981 | $1.266 | -73.71% |
| April, 2030 | $0.5685 | $0.6368 | $0.6222 | -71.29% |
| May, 2030 | $0.8495 | $0.5933 | $0.7402 | -57.10% |
| June, 2030 | $0.6926 | $0.8049 | $0.7985 | -65.02% |
| July, 2030 | $3.7873 | $0.8282 | $5.7872 | +91.28% |
| August, 2030 | $2.8151 | $2.6651 | $8.1151 | +42.18% |
| September, 2030 | $1.143 | $0.873 | $3.3471 | -42.28% |
| October, 2030 | $0.8728 | $0.8529 | $1.3708 | -55.92% |
| November, 2030 | $1.3906 | $0.2167 | $1.5906 | -29.77% |
| December, 2030 | $1.1185 | $0.5765 | $1.5626 | -43.51% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):